Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients

Diabetes Care

Volumn 32, Issue 5, 2009, Pages 810-812

  Hamilton, Sandra J ^a   Chew, Gerard T ^a   Watts, Gerald F ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYICOSATETRAENOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPROSTANE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NITRATE; PLACEBO; PRAVASTATIN; SIMVASTATIN; UBIDECARENONE; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; DRUG DERIVATIVE; UBIQUINONE;

ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DILATATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FATTY ACID BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; URINE LEVEL; BLOOD; BLOOD FLOW VELOCITY; BLOOD PRESSURE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; AGED; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MIDDLE AGED; OXIDATIVE STRESS; PLACEBOS; UBIQUINONE; VASODILATION;

EID: 65949119758     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1736     Document Type: Article

References (15)

1. 10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis.' QJM 2004;97:537-548
2. Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005-2016
3. 10 and statins: biochemical and clinical implications. Mitochondrion 2007;7(Suppl.):S168-S174
4. 10 improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus. Diabetologia 2002;45:420-426
5. Woodman RJ, Playford DA, Watts GF, Cheetham C, Reed C, Taylor RR, Puddey IB, Beilin LJ, Burke V, Mori TA, Green D. Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol 2001;91:929-937 (Pubitemid 32681129)
6. Mori TA, Croft KD, Puddey IB, Beilin LJ. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 1999;268:117-125 (Pubitemid 29115518)
7. Rivera J, Ward N, Hodgson J, Puddey IB, Falck JR, Croft KD. Measurement of 20-hydroxyeicosatetraenoic acid in human urine by gas chromatography-mass spectrometry. Clin Chem 2004;50:224-226 (Pubitemid 38125728)
8. Ward NC, Puddey IB, Hodgson J, Beilin LJ, Croft KD. Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects. Free Radic Biol Med 2005;38:1032-1036 (Pubitemid 40386549)
9. Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP. Effect of coenzyme Q10 administration on endothelial endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 2007;28:2249-2255 (Pubitemid 47428939)
10. Cardillo C, Campia U, Bryant MB, Panza JA. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 2002;106:1783-1787
11. Yasuda S, Miyazaki S, Kanda M, Goto Y, Suzuki M, Harano Y, Nonogi H. Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase. Eur Heart J 2006;27:1159-1165 (Pubitemid 43752386)
12. Stocker R, Pollicino C, Gay CA, Nestel P, Colquhoun D, Whiting M, Tonkin A, Sullivan D, Simes J. Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study. Atherosclerosis 2006;187:198-204 (Pubitemid 43817015)
13. Neunteufl T, Heher S, Katzenschlager R, Wolfl G, Kostner K, Maurer G, Weidinger F. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000;86:207-210 (Pubitemid 30410729)
14. Shimbo D, Grahame-Clarke C, Miyake Y, Rodriguez C, Sciacca R, Di Tullio M, Boden-Albala B, Sacco R, Homma S. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 2007;192:197-203 (Pubitemid 46602298)
15. Widlansky ME, Gokce N, Keaney JF, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003;42:1149-1160 (Pubitemid 37188333)